PTA-Adhoc: HOCHDORF Holding Ltd: New CEO at Pharmalys Laboratories SA
Dr Peter Pfeilschifter assumes role of CEO at Pharmalys Laboratories SA

Monday, 26. August 2019 17:45

Announcement according to SIX adhoc publication article 53 KR

Hochdorf (pta032/26.08.2019/17:45) - Dr Peter Pfeilschifter, currently Chairman of the Board of Directors at Pharmalys Laboratories SA, is to take on the role of CEO at Pharmalys Laboratories SA with immediate effect. Dr Pfeilschifter will take responsibility for the operational business in the next few days. The interim CEO of the HOCHDORF Group will be supported in this additional role by Baby Care team employees at HOCHDORF Swiss Nutrition Ltd. The new CEO appointment became necessary when Amir Mechria resigned from all his responsibilities at Pharmalys Laboratories SA. This development means that HOCHDORF assumes responsibility for the operational business of Pharmalys Laboratories SA.

(end)

emitter: HOCHDORF Holding Ltd
address: Siedereistrasse 9, 6281 Hochdorf
country: Switzerland
contact person: Dr. Christoph Hug
phone: +41 41 914 65 62
e-mail: christoph.hug@hochdorf.com
website: www.hochdorf.com/

ISIN(s): CH0024666528 (share)
stock exchanges: listed in SIX Swiss Exchange

[ source: http://www.pressetext.com/news/20190826032 ]

Related Links: HOCHDORF Holding AG
Author: